TRAVERE THERAPEUTICS INC
TVTX · NASDAQ
Updated at 2026-10-14 10:03:30
- Today's High
- $52.81
- Today’s Low
- $51.38
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $51.74
- Previous Close
- $52.02
- Volume
- 1.42M
- Market Cap
- $4.9B
- P/E Ratio
- --
- EPS
- $-0.49
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 3611 VALLEY CENTRE DRIVE, SAN DIEGO, CA, UNITED STATES, 92130
- Country
- US
- Listing Date
- 2003-07-23
- Fiscal Year End
- December
- Shares Outstanding
- 92.99M
- CIK
- 0001438533
- Website
- travere.com
Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development and commercialization of therapies for the treatment of rare diseases. The company is headquartered in San Diego, California.
Financial Metrics
Revenue
2026-06-30
$169.58M
2026-03-31
$127.19M
2025-12-31
$129.68M
2025-09-30
$164.85M
Operating Expenses
2026-06-30
$163.45M
2026-03-31
$137.34M
2025-12-31
$159.56M
2025-09-30
$138.34M
Net Income
2026-06-30
-$34.79M
2026-03-31
-$37.1M
2025-12-31
$2.72M
2025-09-30
$25.7M
Net Profit Margin
2026-06-30
-20.51%
2026-03-31
-29.16%
2025-12-31
2.1%
2025-09-30
15.59%
Earnings Per Share
2026-06-30
$-0.37
2026-03-31
$0.05
2025-12-31
$0.37
2025-09-30
$0.59
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$28.63M
2026-03-31
-$9.21M
2025-12-31
-$632K
2025-09-30
$44.25M
Effective Tax Rate
2026-06-30
0.58%
2026-03-31
0.32%
2025-12-31
-4.37%
2025-09-30
0.03%
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $169.58M | $127.19M | $129.68M | $164.85M |
| Operating Expenses | $163.45M | $137.34M | $159.56M | $138.34M |
| Net Income | -$34.79M | -$37.1M | $2.72M | $25.7M |
| Net Profit Margin | -20.51% | -29.16% | 2.1% | 15.59% |
| Earnings Per Share | $-0.37 | $0.05 | $0.37 | $0.59 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$28.63M | -$9.21M | -$632K | $44.25M |
| Effective Tax Rate | 0.58% | 0.32% | -4.37% | 0.03% |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.